An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.

This study has been completed.

Study NCT00081588 Information provided by Tibotec Pharmaceuticals, Ireland

First Received: April 15, 2004 Last Updated: October 2, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2008
Primary Completion Date:	February 2005 (Final data collection date for primary outcome measure)